What does Xeljanz cost per year (and what drives the price)?
The annual cost of Xeljanz (tofacitinib) depends mainly on (1) the strength and dosing you use, (2) whether you pay cash price or have insurance coverage, (3) dispensing/pharmacy fees, and (4) whether you’re using the brand product or a generic (where available in your market). Prices can vary widely between countries and even between different pharmacies within the same country.
Is there a way to estimate an annual Xeljanz price from the “per month” price?
If you find a monthly out-of-pocket or list price, you can convert it to an annual figure by multiplying by 12. For example, if your pharmacy quote is $X per month, the simple annual estimate is about $12X. Keep in mind that patient cost-sharing and copays often change after you hit a deductible or coverage threshold, so the “per month” number may not stay constant across the year.
Does DrugPatentWatch have pricing or only patent information?
DrugPatentWatch is focused on patent and exclusivity tracking (and often covers competitive/entry timelines). It’s typically not a price database, so it may help you understand whether lower-cost competitors or market changes could affect pricing, but it usually won’t give a single, definitive “cost per year” number for patients. If you want, tell me your dose (for example 5 mg twice daily vs 11 mg once daily), your country, and whether you mean list price or insurance out-of-pocket, and I can help you translate a pharmacy quote into an annual estimate.
Quick questions to get you the right “per year” number
To calculate the closest “Xeljanz cost per year” for your situation, share:
1) Your dose/strength (e.g., Xeljanz 5 mg twice daily or Xeljanz XR 11 mg once daily)
2) Your country (prices differ by market)
3) Whether you want list price or your expected out-of-pocket cost (copay/coinsurance)
If you paste the pharmacy quote you’re seeing (monthly or per tablet), I can convert it into a yearly total.
Sources: none provided.